A61K 39/255
Marek's disease virus
A61K39/255 (Marek's disease virus) appears on 62 US grants and 43 published applications in this corpus.
Search patents in A61K- Granted patents
- 62
- Published applications
- 43
- Assignees
- 39
- Inventors
- 97
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 3 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 7 | 0 |
| 1999 | 6 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 1 |
| 2002 | 6 | 3 |
| 2003 | 1 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 3 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 2 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 2 |
| 2017 | 1 | 2 |
| 2018 | 3 | 2 |
| 2019 | 2 | 4 |
| 2020 | 2 | 4 |
| 2021 | 0 | 2 |
| 2022 | 3 | 5 |
| 2023 | 0 | 1 |
| 2024 | 0 | 2 |
| 2025 | 5 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant viruses and the uses thereof9 Dec 2025US 12,491,242 B2Ceva Sante Animale
- Genetically modified cell line for production of Marek's disease virus vaccine and methods of making and using the same14 Oct 2025US 12,440,556 B2Zoetis Services LLC
- Modified Marek's disease virus, and vaccines made therefrom22 Apr 2025US 12,280,106 B2Boehringer Ingelheim Animal Health USA Inc.
- Recombinant non-pathogenic Marek's disease virus constructs encoding multiple heterologous antigens4 Mar 2025US 12,239,704 B2Intervet Inc.
- Vaccine delivery method7 Jan 2025US 12,186,390 B2University of Georgia Research Foundation, Inc.
- Cell line for production of marek's disease virus vaccine and methods of making and using the same2 Jul 2026US 2026/0183388 A1Zoetis Services LLC
- Composition comprising dry extract of lyophilised intestinal content of adult chicken, relative use as food supplement and use for stimulating the immune system27 Nov 2025US 2025/0359569 A1Orbiotek Sarl
- New multivalent hvt vector vaccine20 Nov 2025US 2025/0352642 A1Intervet Inc.
- Recombinant hvt vectors expressing influenza hemagglutinin and immunogenic compositions, and production and uses thereof1 Aug 2024US 2024/0252624 A1Boehringer Ingelheim Animal Health USA Inc.
- Reduced foaming vaccine compositions8 Feb 2024US 2024/0042037 A1Abic Biological Laboratories Ltd.
Most cited
By later US patents
- Chicken interleukin-15 and uses thereof88US 6,737,522 B2Wayne State University · 2004
- Recombinant herpesvirus of turkeys comprising a foreign DNA inserted into a non-essential region of the herpesvirus of turkeys genome34US 6,121,043 ASyntro Corporation · 2000
- Multivalent in ovo avian vaccine18US 6,048,535 ARegents of the University of Minnesota · 2000
- Multivalent in ovo avian vaccine13US 6,406,702 B1Regents of the University of Minnesota · 2002
- Live vaccine for contagious diseases of chickens12US 4,980,162 AJuridical Foundation the Chemosero-Therapeutic Research Institute · 1990